Risk factors for in-hospital mortality in patients with cancer and COVID-19

Affiliations

¹ The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
² Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, China.
³ Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
⁴ Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, China. Electronic address: shanmingruan@zcmu.edu.cn.

Comment

Kaibo Guo et al. Lancet Oncol. 2020 Sep.

. 2020 Sep;21(9):e406.

doi: 10.1016/S1470-2045(20)30426-5.

¹ The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
² Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, China.
³ Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
⁴ Department of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, China. Electronic address: shanmingruan@zcmu.edu.cn.

No abstract available

Comment in

Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
Yang K, Sheng Y, Wu B, Wu G. Yang K, et al. Lancet Oncol. 2020 Sep;21(9):e408. doi: 10.1016/S1470-2045(20)30467-8. Lancet Oncol. 2020. PMID: 32888458 Free PMC article. No abstract available.

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Yang K, et al. Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479787 Free PMC article.
Risk factors for in-hospital mortality in patients with cancer and COVID-19.
Zhang G, An Y, Zhang L, Xie L, Guo X. Zhang G, et al. Lancet Oncol. 2020 Sep;21(9):e407. doi: 10.1016/S1470-2045(20)30390-9. Lancet Oncol. 2020. PMID: 32888457 Free PMC article. No abstract available.

1. Yang K, Sheng Y, Huang C. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:904–913. - PMC - PubMed
1. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
1. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442–447. - PMC - PubMed
1. Chai P, Yu J, Ge S, Jia R, Fan X. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis. J Hematol Oncol. 2020;13:43. - PMC - PubMed